PPT-Provider Adherence to Oral Chemotherapy Dose Adjustment Guidelines

UT Clinical Safety amp Effectiveness Conference San Antonio TX October 2728 2011 Amy Fowler MD Alexis Kennedy CPNP Naomi Winick MD The Team Team Members CSampE Participants Amy Fowler MD Project Leader. Maggie Charpentier, PharmD, BCPS. Clinical Associate Professor University of Rhode Island. Per-diem pharmacist: Roger Williams Medical Center. Goal and Objectives. Goal:.  Educate pharmacists regarding counseling and safe dispensing of oral chemotherapy in community pharmacy. Meck Chongo, . Virginia . Russell, . Josée. Lavoie, Ross Hoffman, . Mamdouh. . Shubair. University of Northern British Columbia. Agenda. . Background. Objectives . Participants & Research Environment. Reasons why patients do not adhere. Measuring adherence and non adherence. Improving adherence. Reasons for non-adherence: cognitive rational non-adherence. Adherence is all about being conscientious in following medical advice. . Ronni. AW Wetmore, RN, MS. Coordinator, Stanford Adult Cystic Fibrosis Center. Speaker Bureau: . Chiesi. Pharmaceuticals. Nurse Advisory Board: Genentech Pharmaceutical Company. Nurse Advisory Board: Gilead Pharmaceutical. Doyle M. Cummings, PharmD, FCP, FCCP. Professor of Family Medicine and Public Health. East Carolina University, Brody School of Medicine. Greenville, North Carolina. . [Residency educators may . adapt and use . Cory Theberge, PhD. UNE College of Pharmacy. Karin Wagner, DVM, DACVIM. Maine Veterinary Referral Center. Scarborough, ME . Learning Objectives . Relate the types of cancers seen in cats and dogs, and recall oral chemotherapy dosing and treatment strategies. Lessons from a 3-month Placebo Gel Trial at 3 US sites. Alex Carballo-Diéguez, Ph.D. .. Columbia University, NYC, US. Background. In the USA, young men who have sex with men (YMSM), especially those who are ethnic minorities, have high prevalence and incidence of HIV. Simi Padival, MD. November 3, 2016. Objectives. Learn about the importance of assessing adherence to antiretroviral therapy (ART). Learn about the components of assessing for ART adherence. Discuss frequency of monitoring while on ART. Chapter 16; Pages 797 to 815A. also Section 16.11: Drug Resistance. Folder Title: CxChemoPart1. Updated: . April 23, 2018. Therapeutic Modality Options. Surgery. Radiation: X-Ray; Photodynamic Therapy; Thermal Ablation; Microwave; . PrEP. Version. : December . 2018. Outline of training. Module 1: Introduction to oral PrEP. Oral PrEP: the basics. What is combination prevention?. How effective is oral PrEP? . What are the differences among PrEP, PEP, and ART? . Module 5: MONITORING, FOLLOW-UP, AND ADHERENCE SUPPORT FOR AGYW ON ORAL PrEP Version: August 2018 Initiation and clinical management of PrEP for AGYW Note for facilitator: Initiation, follow-up, and maintenance of PrEP for  . Dr.Thabat. J. Al-. Maiahy. MBChB,DOG,CABOG. Radiotherapy. EXTERNAL RADIATION THERAPY. Indicated when an area to be irradiated is large, . e.g. cx cancer . The basic tent of radiation therapy is to maximize the tumor damage while minimizing the . Infection. If you have a fever or are feeling sick, your chemotherapy may be delayed . This is done for your safety, so you can recover from the infection. If your dose of chemotherapy causes side Jessica Latchman APRN, AGACNP-BC AOCNP, ACHPN. Ann Guastella, APRN, AOCN, ACHPN. December 13, 2022. INTRODUCTION . Chemotherapy induced peripheral Neuropathy is common problem facing cancer patients .